3.0
21. Jan. 2026
Aktueller Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Competitive OTE and provides a satisfying challenge.
Kontras
Biotech market is bad right now and only 1 or 2 salespersons are hitting quota so nobody is making close to their OTE. Constant turnover in leadership and lack of consistent direction